DR1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DR1 Antibodies for advanced research in molecular biology. DR1 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DR1, or the down-regulator of transcription 1, plays a critical role in regulating gene expression and is involved in various cellular processes, including immune response and inflammation. Understanding the function of DR1 is essential for elucidating its impact on diseases such as cancer and autoimmune disorders. Researchers can utilize DR1 monoclonal antibodies to investigate cellular pathways and mechanisms involved in disease progression. Advanced research applications include protein expression analysis, protein-protein interaction studies, and cellular localization experiments. Investigating DR1's role in transcriptional regulation can provide valuable insights into potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for DR1 support researchers worldwide in advancing scientific understanding of disease mechanisms and developing new therapeutic approaches.